Search

Learn how MSK doctors are using proton therapy to treat tumors of the brain and spinal cord.

… Monday, September 30, 2024 People with tumors of the central nervous system (CNS), which includes the brain and spinal cord, are living longer after treatment. The increase in survival makes it even more important to minimize the treatment side effects that can impair day-to-day life. One way Memorial

Three MSK researchers served as guest judges at the event, which celebrated students’ academic achievements.

… Tuesday, May 16, 2023 L to R: Drs. Grady Nelson, Mala Jain, and Tanaya Roychowdhury. The three MSK researchers served as judges of the District 9 science fair at Yankee Stadium on May 6, 2023. L to R: Drs. Grady Nelson, Mala Jain, and Tanaya Roychowdhury. The three MSK researchers served as judges of

A team of Memorial Sloan Kettering scientists has come up with an approach to make stem-cell-derived neurons rapidly age in a cell culture dish. The breakthrough could transform research into Parkinson’s and other late-onset diseases.

… Monday, December 30, 2013 Summary A team of Memorial Sloan Kettering scientists has come up with an approach to make stem-cell-derived neurons rapidly age in a cell culture dish. The breakthrough could transform research into Parkinson’s and other late-onset diseases. Methods to generate artificial stem

Memorial Sloan Kettering Cancer Center (MSK) has announced that Debra Berns has been named as MSK’s Senior Vice President and Chief Risk Officer following an extensive national search.

… Wednesday, April 18, 2018 Memorial Sloan Kettering Cancer Center (MSK) has announced that Debra Berns has been named as MSK’s Senior Vice President and Chief Risk Officer following an extensive national search. Ms. Berns will oversee MSK’s compliance, conflict of interest, and internal audit functions

… Monday, June 30, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:  Brendan Camellato Named a 2025 Jane Coffin Childs Fund for Medical Research Fellow Brendan Camellato, PhD , Brendan Camellato postdoctoral research scholar, was selected for the

The breakthrough gives an unprecedented look at the varied and shifting poses of a protein in action.

… Monday, June 10, 2019 Summary Scientists at the Sloan Kettering Institute have combined biochemical and computational methods to visualize how an important cancer-related protein changes shape during a chemical reaction. The results will aid drug design. A goal of chemical biology is to characterize

A new study by researchers at Memorial Sloan Kettering Cancer Center reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone - the two most prominent sites of lung cancer relapse.

… Thursday, July 2, 2009 A new study by researchers at Memorial Sloan Kettering Cancer Center (MSKCC) reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone - the two most prominent sites of lung cancer relapse. The study will be published

A new multi-center study shows that an experimental drug lowers prostate specific antigen (PSA) levels - a marker for tumor growth - in men with advanced prostate cancer for whom traditional treatment options have failed.

… Thursday, April 9, 2009 A new multi-center study shows that an experimental drug lowers prostate specific antigen (PSA) levels - a marker for tumor growth - in men with advanced prostate cancer for whom traditional treatment options have failed. The study, led by researchers at Memorial Sloan Kettering

By uncovering the root cause of cytokine release syndrome, MSK researchers have found a way to stop it.

… Monday, May 28, 2018 Summary Researchers at the Sloan Kettering Institute have identified the cause of a serious immunotherapy side effect as well as ways to stop or prevent it. The study was done in mice but the approach will soon be tested in people. CAR T cell therapy CAR T cell therapy is helping

MSK Drs. Larry Norton, Dana Pe’er, and Sohrab Shah know cancer research isn’t all beakers and test tubes — computers and algorithms are some of the most powerful tools in cancer research.

… Saturday, July 1, 2023 By Ian Demsky The field of oncology hums with data. Imaging scans, laboratory tests, tumor mutations, medications and dosage — they’re all captured in electronic record systems. There’s a clinical record of how a person was treated and how the cancer they had responded to the treatment